Inmunidad de las Mucosas y Alergia: de la Inmunopatología a la Terapia.
Complejo Asistencial Universitario de León
León, EspañaPublicaciones en colaboración con investigadores/as de Complejo Asistencial Universitario de León (29)
2024
-
Sex-Related Differences in the Phenotype and Course of Inflammatory Bowel Disease: SEXEII Study of ENEIDA
Clinical Gastroenterology and Hepatology, Vol. 22, Núm. 11, pp. 2280-2290
-
Trends in Targeted Therapy Usage in Inflammatory Bowel Disease: TRENDY Study of ENEIDA
Pharmaceutics, Vol. 16, Núm. 5
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Incidence, and natural history of inflammatory bowel disease in Castilla y León: Prospective and multicenter epidemiological study
Gastroenterologia y Hepatologia, Vol. 46, Núm. 2, pp. 102-108
2022
-
Correction: Chaparro et al. Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study (J. Clin. Med., (2021), 10, (2885), 10.3390/jcm10132885)
Journal of Clinical Medicine
-
Immigrant IBD Patients in Spain Are Younger, Have More Extraintestinal Manifestations and Use More Biologics Than Native Patients
Frontiers in Medicine, Vol. 9
-
Novel genes and sex differences in COVID-19 severity
Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806
2021
-
Coeliac disease in elderly patients: Value of coeliac lymphogram for diagnosis
Nutrients, Vol. 13, Núm. 9
-
Incidence, clinical characteristics and management of inflammatory bowel disease in spain: Large-scale epidemiological study
Journal of Clinical Medicine, Vol. 10, Núm. 13
2018
-
Long-term safety of in utero exposure to anti-TNFα drugs for the treatment of inflammatory bowel disease: Results from the multicenter European TEDDY study
American Journal of Gastroenterology, Vol. 113, Núm. 3, pp. 396-403
2017
-
Evolution after Anti-TNF Discontinuation in Patients with Inflammatory Bowel Disease: A Multicenter Long-Term Follow-Up Study
American Journal of Gastroenterology, Vol. 112, Núm. 1, pp. 120-131
2016
-
Infliximab in ulcerative colitis: Real-life analysis of factors predicting treatment discontinuation due to lack of response or colectomy: ECIA (ACAD Colitis and Infliximab Study)
Scandinavian Journal of Gastroenterology, Vol. 51, Núm. 2, pp. 186-195
2015
-
Resources utilization and costs the year before and after starting treatment with adalimumab in Crohn's disease patients
Inflammatory Bowel Diseases, Vol. 21, Núm. 7, pp. 1631-1640
2014
-
Conflictos éticos en el establecimiento de niveles asistenciales en la trisomía 18
Anales de Pediatria
-
Risk of colectomy in patients with ulcerative colitis under thiopurine treatment
Journal of Crohn's and Colitis, Vol. 8, Núm. 10, pp. 1287-1293
2013
-
Do serum C-reactive protein and Interleukin-6 predict kidney scarring after urinary tract infection?
Indian Journal of Pediatrics, Vol. 80, Núm. 12, pp. 1002-1006
2009
2008
-
Celiac disease
Medicina Clinica, Vol. 131, Núm. 7, pp. 264-270
-
Urinary interleukin-6 is useful in distinguishing between upper and lower urinary tract infections
Pediatric Nephrology, Vol. 23, Núm. 3, pp. 429-433